I am backing calls from the Less Survivable Cancers Taskforce (LSCT) to end a vicious cycle which has seen survivability stagnate amongst the six deadliest cancers over the last decade.
I met charity members of the LSCT in the House of Commons on 4 February to coincide with World Cancer Day.
The LSCT represents six ‘less survivable cancers’, lung, liver, brain, oesophageal, pancreatic and stomach, with an average five-year survival rate of 14% due to a legacy of neglect and underfunding. The Taskforce aims to double the survivability of these cancers to 28% by 2029.
At the event, I met cancer specialists and patients with first-hand experience of these ‘less survivable cancers’. I learnt about the critical situation for people diagnosed with these cancers and the urgent need for a step change in targeted investment in research in order to make much-needed diagnosis and treatment breakthroughs.